01 2ABC Farmaceutici SpA
02 2Abdi Ibrahim
03 6Accord healthcare
04 4Actavis Inc
05 11Actelion Pharmaceuticals Ltd
06 4Alembic Pharmaceuticals Limited
07 12Alphapharm PTY Ltd
08 2Alvogen
09 2Amneal Pharmaceuticals
10 12Apotex Inc
11 4Aurobindo Pharma Limited
12 2Centocor
13 2Chartwell Pharmaceuticals llc
14 12Dr Reddy's Laboratories (Australia) Pty Ltd
15 2ENDO OPERATIONS
16 4Generic Health
17 2Helsinn Advanced Synthesis
18 2Hikma Pharmaceuticals
19 2Humanis
20 2Intas Pharmaceuticals
21 4Janssen-Cilag
22 2Laboratorio Eczane Pharma
23 2Marklas Nederland BV
24 2Mepha Pharma
25 3Natco Pharma
26 2Natco Pharma (Canada) Inc
27 4Pharmascience Inc.
28 2Pluviaendo
29 1Precise Group
30 2Sandoz B2B
31 16Sun Pharmaceutical Industries Limited
32 2Taro Pharmaceutical Industries
33 2Teva Pharmaceutical Industries
34 4Viatris
35 4World Medicine
36 2Zim Laboratories
37 3Zydus Pharmaceuticals
01 6Antic-calc Tablet, Film Coated
02 1Bosentan 125Mg 56 Combined Oral Use
03 1Bosentan 32Mg 56 Combined Oral Use
04 1Bosentan 62.5Mg 56 Combined Oral Use
05 2Coated Tablets
06 2DC Granules and Tablets
07 1DISPERSIBLE TABLET
08 10FILM COATED PILL
09 2FILM COATED TABLET
10 4Film Coated Tablet
11 2Film Coated Tablet
12 2Film Coated Tablets
13 12Film-Coated Tablets
14 4Filmtable
15 12TABLET
16 2TABLET, FOR SUSPENSION;ORAL
17 25TABLET;ORAL
18 2TABLETS
19 5Tablet
20 52tablet
01 16DISCN
02 9Generic
03 2Prescription
04 9RX
05 112Blank
01 24BOSENTAN
02 2BOSENTAN ABDI
03 2BOSENTAN ACCORD
04 2BOSENTAN AUROBINDO
05 12BOSENTAN DR.REDDY'S
06 2BOSENTAN MYLAN
07 2BOSENTAN SUN
08 2BOSENTAN TEVA
09 12Bosentan APO
10 2Bosentan Accord
11 4Bosentan GH
12 12Bosentan Mylan
13 12Bosentan RBX
14 2Bosentan Sandoz
15 2Bosentan-Mepha
16 2Endotan
17 2NAT-BOSENTAN
18 4PMS-BOSENTAN
19 2SENTARIN
20 2STAYVEER
21 2TARO-BOSENTAN
22 7TRACLEER
23 2Trac Leer
24 10Tracleer
25 2Tractan
26 2bosentan Accord
27 2bosentan Actavis
28 2bosentan Aurobindo
29 13Blank
01 2Argentina
02 52Australia
03 10Canada
04 7India
05 17Italy
06 6Norway
07 11Sweden
08 6Switzerland
09 10Turkey
10 27USA
Regulatory Info : RX
Registration Country : USA
Brand Name : BOSENTAN
Dosage Form : TABLET;ORAL
Dosage Strength : 62.5MG
Packaging :
Approval Date : 2019-04-26
Application Number : 207110
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : BOSENTAN
Dosage Form : TABLET;ORAL
Dosage Strength : 125MG
Packaging :
Approval Date : 2019-04-26
Application Number : 207110
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : TRACLEER
Dosage Form : TABLET;ORAL
Dosage Strength : 62.5MG
Packaging :
Approval Date : 2001-11-20
Application Number : 21290
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : TRACLEER
Dosage Form : TABLET;ORAL
Dosage Strength : 125MG
Packaging :
Approval Date : 2001-11-20
Application Number : 21290
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : TRACLEER
Dosage Form : TABLET, FOR SUSPENSION;ORAL
Dosage Strength : 32MG
Packaging :
Approval Date : 2017-09-05
Application Number : 209279
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BOSENTAN
Dosage Form : TABLET;ORAL
Dosage Strength : 62.5MG
Packaging :
Approval Date : 2020-01-23
Application Number : 211461
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BOSENTAN
Dosage Form : TABLET;ORAL
Dosage Strength : 125MG
Packaging :
Approval Date : 2020-01-23
Application Number : 211461
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : Generic
Registration Country : India
Brand Name :
Dosage Form : TABLET
Dosage Strength : 62.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BOSENTAN
Dosage Form : TABLET;ORAL
Dosage Strength : 62.5MG
Packaging :
Approval Date : 2019-04-26
Application Number : 206002
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BOSENTAN
Dosage Form : TABLET;ORAL
Dosage Strength : 125MG
Packaging :
Approval Date : 2019-04-26
Application Number : 206002
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BOSENTAN
Dosage Form : TABLET;ORAL
Dosage Strength : 62.5MG
Packaging :
Approval Date : 2019-04-26
Application Number : 209742
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BOSENTAN
Dosage Form : TABLET;ORAL
Dosage Strength : 125MG
Packaging :
Approval Date : 2019-04-26
Application Number : 209742
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BOSENTAN
Dosage Form : TABLET;ORAL
Dosage Strength : 62.5MG
Packaging :
Approval Date : 2020-01-03
Application Number : 210342
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BOSENTAN
Dosage Form : TABLET;ORAL
Dosage Strength : 125MG
Packaging :
Approval Date : 2020-01-03
Application Number : 210342
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BOSENTAN
Dosage Form : TABLET;ORAL
Dosage Strength : 62.5MG
Packaging :
Approval Date : 2019-04-26
Application Number : 208695
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BOSENTAN
Dosage Form : TABLET;ORAL
Dosage Strength : 125MG
Packaging :
Approval Date : 2019-04-26
Application Number : 208695
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BOSENTAN
Dosage Form : TABLET;ORAL
Dosage Strength : 62.5MG
Packaging :
Approval Date : 2019-04-26
Application Number : 206987
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BOSENTAN
Dosage Form : TABLET;ORAL
Dosage Strength : 125MG
Packaging :
Approval Date : 2019-04-26
Application Number : 206987
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : BOSENTAN
Dosage Form : TABLET, FOR SUSPENSION;ORAL
Dosage Strength : 32MG
Packaging :
Approval Date :
Application Number : 213154
Regulatory Info :
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : BOSENTAN
Dosage Form : TABLET;ORAL
Dosage Strength : 62.5MG
Packaging :
Approval Date : 2019-04-26
Application Number : 209324
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : BOSENTAN
Dosage Form : TABLET;ORAL
Dosage Strength : 125MG
Packaging :
Approval Date : 2019-04-26
Application Number : 209324
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BOSENTAN
Dosage Form : TABLET;ORAL
Dosage Strength : 62.5MG
Packaging :
Approval Date : 2020-01-15
Application Number : 205173
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BOSENTAN
Dosage Form : TABLET;ORAL
Dosage Strength : 125MG
Packaging :
Approval Date : 2020-01-15
Application Number : 205173
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : Generic
Registration Country : Turkey
Brand Name :
Dosage Form : FILM COATED TABLET
Dosage Strength : 62.5MG
Packaging : 56 Tablets
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : Turkey
Regulatory Info : Generic
Registration Country : Turkey
Brand Name :
Dosage Form : FILM COATED TABLET
Dosage Strength : 125MG
Packaging : 56 Tablets
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : Turkey
Regulatory Info : RX
Registration Country : USA
Brand Name : BOSENTAN
Dosage Form : TABLET;ORAL
Dosage Strength : 62.5MG
Packaging :
Approval Date : 2019-04-26
Application Number : 207760
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : BOSENTAN
Dosage Form : TABLET;ORAL
Dosage Strength : 125MG
Packaging :
Approval Date : 2019-04-26
Application Number : 207760
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : BOSENTAN
Dosage Form : TABLET;ORAL
Dosage Strength : 32MG
Packaging :
Approval Date :
Application Number : 213981
Regulatory Info :
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BOSENTAN
Dosage Form : TABLET;ORAL
Dosage Strength : 62.5MG
Packaging :
Approval Date : 2019-04-26
Application Number : 205699
Regulatory Info : DISCN
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BOSENTAN
Dosage Form : TABLET;ORAL
Dosage Strength : 125MG
Packaging :
Approval Date : 2019-04-26
Application Number : 205699
Regulatory Info : DISCN
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
LOOKING FOR A SUPPLIER?